split-banner-image

IBCSG 23-01

Closed

IBCSG 23-01: Sentinel Lymph Node Biopsy (Micrometastases)

A randomised trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node.

international

900

INTERNATIONAL

Total number of trial

participants internationally

australia & new zealand

34

AUSTRALIA & NEW ZEALAND

Total number of trial participants

in Australia and New Zealand

institutions

14

INSTITUTIONS

Total number of participating institutions

in Australia and New Zealand

IBCSG 23-01 PUBLICATIONS

2018

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Galimberti V, Cole BF, Viale G, Peronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch The Lancet Oncology 2018; 19(10):1385-1393 (epub 5 September 2018), DOI: https://doi.org/10.1016/S1470-2045(18)30380-2, Journal

2017

Axillary dissection vs. no axillary dissection in patients with cT1-T2cN0M0 breast cancer and only micrometastases in the sentinel node(s): Ten-year results of the IBCSG 23-01 trial.

Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Egli T, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A. SABCS 2017; GS5-02 (oral presentation), Presentation

2013

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay J-R, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U for the IBCSG Trial 23-01 investigators Lancet Oncology 2013; 14297-305, Journal

2011

Update of International Breast Cancer Study Group Trial 23-01 To Compare Axillary Dissection Versus No Axillary Dissection in Patients with Clinically Node Negative Breast Cancer and Micrometastases in the Sentinel Node.

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Massarut S, Garbay J-R, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert, M, Price KN, Goldhirsch A, Gelber RD, Veronesi U. International Breast Cancer Study Group Trial 23-01 Investigators Cancer Research 2011; 71(24)(Suppl.):102s, SABCS Abstract S3-1, Abstract

Institutions